Home 2015
Archives
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
ASCO: MMR Deficiency Predicts Pembrolizumab Response
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
ASCO: Risks of Whole Brain Radiotx May Outweigh Benefits
Second study suggests new immunotherapy may benefit patients with glioblastoma
Ocular Bacteria Differ for Contact Lens Wearers
Finding may explain why lens wearers are more prone to infection
eGFR, ACR Improve Cardiovascular Risk Prediction
Addition of eGFR, ACR ups discrimination of CV outcomes above traditional risk factors
Remote Ischemic Preconditioning Cuts Kidney Injury Risk
Findings among patients at high risk of acute kidney injury, undergoing cardiac surgery
ASCO: Greater Breast Tissue Removal Reduces Further Surgery
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer
ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
ASCO: Lymph Node Sx Doesn’t Benefit All Melanoma Patients
Second study supports new immunotherapy for enhanced survival in advanced melanoma
Smoke Exposure May Create Need for More Anesthesia
Effect seems to extend to patients exposed to secondhand smoke, as well as smokers
